CYTO365 looking for 2MEUR to co-invest with EIC Fund

CYTO365 have invested and developed an innovative production line for high volume capacity at Low Cost Of Goods, in its own GMP-C class cleanroom in Helsingborg, Sweden, to be able to reach mass market adoption fast, of our RondelO component. RondelO solves the unmet need of a physical barrier to avoid drug mixing in of multiple drugs that are involved for instance in oncology. We have also developed a complete range of IV-sets and we have customers globally already. We looking for the last 3 MEUR to scale up business in the commercialisation phase. But hold on and buckle up, this previous pilot CEO will offer a trajectory you never have seen before together with its co-founder Registered Nurse Oncology specialist and the rest of the CYTO365 team. With 4 years of building network our pipeline of potential customer base is large. We see now a clear paradigm shift in that before we convinced companies to try RondelO and now they ask for RondelO. With 8 patent families and total over 100+ patents approved we fell confident that we are in a good position. I will be at the EIC summit and look forward to connect with investors, VC/angles or partner that can help us fundraise the 3 MEUR need until we reach break even.

Please look on our website for more info:

For Healthcare segment (Main business)

www.cyto365.com
https://www.cyto365.com/solutions/catalogue-iv-set/
https://www.cyto365.com/solutions/catalogue-components/

For Industry segment:

www.rondelo.io